Pharmacological Characteristics and Control Efficacy of a Novel SDHI Fungicide Pydiflumetofen Against Sclerotinia sclerotiorum.

Pydiflumetofen is a novel succinate dehydrogenase inhibitor fungicide. In the current research, we determined the sensitivity of 166 Sclerotinia sclerotiorum strains to pydiflumetofen using mycelial growth inhibition method. The results suggest that pydiflumetofen exhibited a strong inhibitory activity against S. sclerotiorum and the EC values ranged from 0.0058 to 0.0953 μg ml, with a mean EC value of 0.0250 μg ml. However, the baseline sensitivity was not normally distributed because of a high variation factor. After treatment with pydiflumetofen, cell membrane permeability increases, but exopolysaccharide and oxalic acid production decreases, which contributes to reduced virulence of S. sclerotiorum and leads to failure of disease infection. In addition, protective and curative activity was performed on detached oilseed rape leaves by artificial inoculation. Pydiflumetofen exhibited excellent protective and curative effects against S. sclerotiorum on oilseed rape, and the protective effect was better than the curative effect. Further, field trials were conducted to evaluate the potential of pydiflumetofen in controlling Sclerotinia stem rot (SSR) caused by S. sclerotiorum on oilseed rape. Compared with the currently used fungicides, pydiflumetofen not only exhibited excellent control efficacy against SSR, but also dramatically reduced the dosage of fungicides in the field. Thus, this study provides important references for revealing pharmacological mechanism of pydiflumetofen against S. sclerotiorum and managing SSR on oilseed rape caused by benzimidazole- and dicarboximide-resistant populations.